GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →

Biotechnology

Latest articles

Image for UK's Oxford Biomedica tumbles after annual revenue forecast cut
Finance

UK's Oxford Biomedica tumbles after annual revenue forecast cut

Aug 7 (Reuters)Durham, NC - Britain's Oxford Biomedica fell more than 24% on Friday after the cell a...

7th August, 2026

Image for Novartis to acquire UK-based Myricx Bio for up to $1.5 billion
Finance

Novartis to acquire UK-based Myricx Bio for up to $1.5 billion

ZURICH, July 6 (Reuters) - Swiss drugmaker Novartis said on Monday it had agreed to pay up to $1.5 b...

6th July, 2026

Image for Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip
Finance

Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip

By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Swiss pharmaceutical and d...

29th June, 2026

Image for French biotech company Ipsen to buy Kartos Therapeutics for $450 million
Finance

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

June 29 (Reuters) - Ipsen will buy U.S.-based Kartos Therapeutics for $450 million to expand its onc...

29th June, 2026

Image for Russia overhauls vaccine production after cattle disease triggers mass culling
Finance

Russia overhauls vaccine production after cattle disease triggers mass culling

MOSCOW, March 30 - Russian President Vladimir Putin signed a decree on Monday overhauling the produc...

30th March, 2026

Image for MARY TANNER APPOINTED TO GENTICEL’S SUPERVISORY BOARD AS INDEPENDENTLY-ACTING MEMBER
Top Stories

MARY TANNER APPOINTED TO GENTICEL’S SUPERVISORY BOARD AS INDEPENDENTLY-ACTING MEMBER

GENTICEL (Euronext Paris and Brussels: FR0011790542 – GTCL), a French biotechnology company an...

23rd September, 2014

Image for STEM CELL SECTOR OFFERS INVESTORS RETURNS TO REGENERATE THEIR INVESTMENT PORTFOLIOS
Business

STEM CELL SECTOR OFFERS INVESTORS RETURNS TO REGENERATE THEIR INVESTMENT PORTFOLIOS

Investors looking for a sector that has been largely overlooked, but which has the potential to deli...

5th September, 2014

Image for INNOVATIVE BIOSCIENCE COMPANY CELL GUIDANCE SYSTEMS RAISES £243K ON CROWDCUBE INVESTMENT TARGET BEATEN BY ALMOST 150%
Top Stories

INNOVATIVE BIOSCIENCE COMPANY CELL GUIDANCE SYSTEMS RAISES £243K ON CROWDCUBE INVESTMENT TARGET BEATEN BY ALMOST 150%

Capital will finance CGS’s growth in the dynamic stem cell research sector Cambridge based Cell Guid...

28th October, 2013